Background: Exercise rehabilitation is highly recommended by current guidelines on prevention of cardiovascular disease, but its implementation is still poor. Many clinicians experience difficulties in prescribing exercise in the presence of different concomitant cardiovascular diseases and risk factors within the same patient. It was aimed to develop a digital training and decision support system for exercise prescription in cardiovascular disease patients in clinical practice: the European Association of Preventive Cardiology Exercise Prescription in Everyday Practice and Rehabilitative Training (EXPERT) tool. Methods: EXPERT working group members were requested to define (a) diagnostic criteria for specific cardiovascular diseases, cardiovascular disease risk factors, and other chronic non-cardiovascular conditions, (b) primary goals of exercise intervention, (c) disease-specific prescription of exercise training (intensity, frequency, volume, type, session and programme duration), and (d) exercise training safety advices. The impact of exercise tolerance, common cardiovascular medications and adverse events during exercise testing were further taken into account for optimized exercise prescription. Results: Exercise training recommendations and safety advices were formulated for 10 cardiovascular diseases, five cardiovascular disease risk factors (type 1 and 2 diabetes, obesity, hypertension, hypercholesterolaemia), and three common chronic non-cardiovascular conditions (lung and renal failure and sarcopaenia), but also accounted for baseline exercise tolerance, common cardiovascular medications and occurrence of adverse events during exercise testing. An algorithm, supported by an interactive tool, was constructed based on these data. This training and decision support system automatically provides an exercise prescription according to the variables provided. Conclusion: This digital training and decision support system may contribute in overcoming barriers in exercise implementation in common cardiovascular diseases.
Introduction
Exercise training is a cornerstone in the prevention and treatment of cardiovascular disease (CVD), as it leads to reductions in cardiovascular (CV) event rates, hospitalisations, and improves CVD risk profile, exercise capacity, muscle strength and endurance, quality of life and life expectancy in patients with CVD (risk). [1] [2] [3] [4] Participation in preventive programmes for therapy optimisation, adherence and risk factor management, that include exercise training, are now recommended for patients with CVD to reduce disease recurrence by the 2016 European guidelines for CVD prevention. 5 To facilitate implementation of exercise training intervention in the treatment of patients with CVD (risk), clinical recommendations have been published. 5 In general, it is recommend that CVD patients should execute >150 min per week of endurance exercise training, ideally spread over three to five days per week. It is advised to initiate the exercise training intervention at a low(er) exercise intensity, and gradually increase this intensity. An energy expenditure of 1000-2000 kcal per week should be achieved, and endurance exercise training should be complemented by resistance exercise training two times per week at a moderate exercise intensity. 5 Also, neuromotor training involving balance, agility and coordination exercise are recommended in specific indications.
However, evidence is accumulating that a different exercise prescription is required when different goals are aimed at (e.g. for reducing adipose tissue mass, improving blood lipid profile, exercise tolerance or glycaemic control, etc.) and according to the severity of CVD. 6 For example, it has been shown that in type 2 diabetes patients a higher exercise training frequency is key to greater clinical benefits (improvement in glycaemic control), 7 while in patients with symptomatic peripheral arterial disease walking, but not cycling, exercise training leads to improvements in walking capacity. 8 Tailoring the exercise training programme to each single patient according to his/her specificity is thus a crucial aspect in this endeavour. However, clinicians are confronted with the difficulty of properly prescribing exercise in the presence of combinations of CVDs, CVD risk factors and/or other chronic non-CV diseases within the same patient, and keeping patients adherent to the prescribed programme. Indeed, a large heterogeneity in exercise prescription (exercise type, frequency, volume, intensity, session and programme duration) has been shown in CV rehabilitation programmes. [9] [10] [11] [12] [13] [14] [15] [16] With this in mind, the European Association of Preventive Cardiology (EAPC) aimed to optimise exercise prescription in patients with different CVDs and risk factors by the publication of recommendations for prescription of specific exercise training modalities for patients with different CVD risk factors or CVDs. 17, 18 However, these recommendations remained distinct between different CVDs and risk factors. Yet, the challenge for clinical practice is how to combine these different exercise training guidelines, taking into account CV medication intake, presence of common non-CV co-morbidities, and adverse events during exercise testing, when shaping an exercise prescription for a single individual. We hypothesised that CV rehabilitation specialists could potentially benefit from a digital training and decision support system that assists them in exercise prescription. 19 Due to the complexity, such a tool must be able to define or advise automatically which exercise training programme should be prescribed.
The aim of the present paper is to describe the concept, definitions and construction methodology of a digital training and decision support system for exercise prescription for patients with CVD: the EAPC Exercise Prescription in Everyday Practice and Rehabilitative Training (EXPERT) tool. This tool is an interactive, digital training and decision support system that assists healthcare professionals to prescribe clinically effective and medically safe exercise training programmes for CVD patients. With such a tool, we aim to optimise exercise prescription for patients with CVD (risk), and hereby to contribute to increased short-and long-term clinical benefits.
In this article, the activities and composition of the EXPERT working group are described, and thereafter the EXPERT tool construction methodology and use. Finally, exercise training recommendations for five imaginary cases (see Appendix 1), as generated by the EXPERT tool, are compared with exercise training recommendations generated by 18 cardiologists/CV rehabilitation specialists.
EAPC EXPERT working group
A working group of dedicated and experienced rehabilitation specialists from different European countries was first composed. Not all working group members were involved in the development of the EXPERT tool from the beginning. Some members agreed to participate at a later stage of the project. All contributors were chosen based on their scientific and/or clinical expertise.
Contributors and collaborations within EXPERT working group
The EXPERT working group involved 33 experts in the rehabilitation of chronic internal diseases, and three computer science experts, from 11 European countries (see author list).
Specific goals of the EXPERT working group
An interactive digital training and decision support system for exercise prescription was developed by the EXPERT project working group, and was endorsed by the EAPC. The goals of the EAPC are to optimise the implementation of, to spread scientific knowledge of, and to educate clinicians in secondary CV prevention. The following targets in the EXPERT project were agreed:
1. To design a digital training and decision support system that assists healthcare professionals to choose and adopt the most optimal exercise training intervention for CVD (risk) patients. 
Target audience of EXPERT tool
The EXPERT tool is made and designed for cardiologists, physiotherapists, clinical exercise physiologists and/or nurses specifically involved in CV rehabilitation. The EXPERT tool may also be used by sport-and exercise medicine specialists, family physicians or endocrinologists, although it must be guaranteed that the exercise training intervention will be implemented in the proper setting with sufficient and specialised supervision. In the end, the implementation of exercise training intervention remains the full responsibility of the healthcare professional, i.e. the generated exercise prescription by the EXPERT tool must always be evaluated by sufficiently educated physicians or allied healthcare professionals.
Methodology of construction of EXPERT tool

Contributor tasks
The chronology and passed timelines of EXPERT working group activities are displayed in Appendix 2. Working group members were allocated to specific CVDs, CVD risk factors, or other chronic non-CV comorbidities after the first official meeting (see author list), and were requested to (a) provide definitions or diagnostic criteria, (b) define the primary goal of exercise training intervention, (c) specify exercise training recommendations, and (d) indicate exercise training safety advice. These recommendations and definitions had to be based on (preferably in following order) current clinical guidelines and position statements, metaanalyses, systematic reviews, randomised controlled trials, cohort studies, observational studies or expert opinions. These recommendations and definitions were collected by the project coordinator who collaborated with computer science experts to construct the EXPERT tool.
Definitions and diagnostic criteria of diseases and risk factors
The different CVDs, commonly presented chronic non-CV diseases, and CVD risk factors were defined according to international guidelines (see Table 1 ). These standards and criteria are also used in the EXPERT tool.
Exercise intervention goals
For each different CVD, CVD risk factor and other chronic non-CV co-morbidity, specific exercise intervention goals were formulated (see Table 2 ). These goals were selected as they are known to be associated with clinical status or morbidity/mortality. Exercise training prescriptions were based on these exercise intervention goals.
Construction and use of the tool
Step 1: patient characteristics Clinicians using the EXPERT tool have to fill out the patient's name, date of birth, body height and weight (from which body mass index (BMI) is calculated automatically), systolic and diastolic blood pressure, blood total and low-density lipoprotein (LDL) cholesterol concentration, fasting glycaemia, resting and peak heart rate during exercise testing, and peak oxygen uptake capacity (from which percentage of reference value is automatically calculated). 36 When certain thresholds of CVD risk factors are exceeded, these risk factors are automatically activated (with their corresponding exercise prescription). Based on percentage of normal peak oxygen uptake capacity, clinicians are alerted to adjust the initial exercise intensity accordingly. Resting heart rate and heart rate during peak exercise are used for detailed exercise intensity prescription (based on the Karvonen formula). If certain data are not available (e.g. from exercise testing) the EXPERT tool still functions, but does not take into account these missing values for the generation of exercise prescription.
Step 2: CVDs, CVD risk factors, and other chronic non-CV co-morbidities Clinicians using the EXPERT tool are able to select one or more of the following CVDs and CVD risk factors: primary indications for rehabilitation (e.g. coronary artery disease (with or without percutaneous coronary intervention (PCI), coronary artery bypass graft (CABG) surgery, or endoscopic atraumatic CABG (endo-ACAB) surgery, heart failure (with preserved or lowered left ventricular ejection fraction), cardiomyopathy, intermittent claudication, implantable cardioverter defibrillator (ICD) or pacemaker, ventricular assist devices, heart transplantation, valve disease or surgery, congenital heart disease, pulmonary hypertension), CVD risk factors (e.g. type 1 and 2 diabetes, obesity, hypertension, hypercholesterolaemia/dyslipidaemia). In addition, clinicians can select one or more chronic non-CV diseases to fine-tune the exercise training 20, 21 Significant coronary stenosis in one or more coronary arteries (50% stenosis), or patients with symptoms of angina pectoris during exercise, with or without coronary revascularisation by percutaneous coronary intervention or coronary artery bypass graft.
Heart failure 22 Typical symptoms (e.g. breathlessness, ankle swelling, and fatigue) and signs (e.g. elevated jugular venous pressure, pulmonary crackles, and displaced apex beat) resulting from an abnormality of cardiac structure or function (diminished cardiac output, diagnosed by echocardiography) due to long-standing hypertension, myocardial ischaemia/infarction, valve disease, obesity and/or diabetes. Both diastolic (preserved left-ventricular ejection fraction) and systolic (reduced left ventricular ejection fraction) heart failure are included. Pulmonary hypertension 27 An increase in mean pulmonary arterial pressure 25 mm Hg at rest as assessed by right heart catheterisation.
Intermittent claudication 28 The development of symptoms (reduced walking capacity and intermittent leg pain that is provoked by walking) related to peripheral arterial disease: an ankle-brachial index of 0.8 or the mean of three ankle-brachial indexes of 0.90, or having undergone peripheral arterial revascularisation.
Pacemaker and implantable cardioverter defibrillator Presence of pacemaker or implantable cardioverter defibrillator.
Ventricular assist devices
Presence of ventricular assist device.
Cardiac transplantation
Presence of transplanted heart. Idiopathic interstitial lung disease: is a specific form of chronic, progressive fibrosing interstitial pneumonia of unknown cause, occurring primarily in older adults, limited to the lungs, and associated with the histopathologic and/or radiologic pattern of a usual interstitial pneumonia. It requires exclusion of other known causes of interstitial lung disease (e.g. domestic and occupational environmental exposures, connective tissue disease, and drug toxicity), the presence of a usual interstitial pneumonia pattern on high-resolution computed tomography in patients not subjected to surgical lung biopsy, and specific combinations of high-resolution computed tomography and surgical lung biopsy pattern in patients subjected to surgical lung biopsy.
Renal failure (patients on dialysis) 33 A glomerular filtration rate level less than 60 ml/min per 1.73 m Congenital heart disease 35 Atrial septal defect, ventricular septal defect, atrioventricular septal defect, patent ductus arteriosus, left ventricular outflow tract obstruction, coarctation of the aorta, Marfan syndrome, right ventricular outflow tract obstruction, Ebstein's anomaly, tetralogy of Fallot, pulmonary atresia with ventricular septal defect, transposition of the great arteries, congenitally corrected transposition of the great arteries, univentricular heart, patients after Fontan operation, right ventricular to pulmonary artery conduit, Eisenmenger syndrome and severe pulmonary arterial hypertension.
In-hospital phase
Being hospitalised for at least three consecutive days.
FEV: forced expiratory volume; FVC: forced viral capacity; T2DM: type 2 diabetes mellitus.
prescription, such as sarcopaenia, chronic pulmonary disease or renal insufficiency/failure. The decision to divide the above-mentioned diseases into primary indications, CVD risk factors, and other chronic non-CV co-morbidities may be pragmatic, but it reflects the clinical practice in exercise prescription for CVD (risk) and increases the feasibility and user experience of the EXPERT tool.
Step 3: CV medication interactions
Medications with significant repercussions for exercise prescription and performance are included: betablockers (they alter target exercise heart rate), statins (they may cause myopathy and lower exercise tolerance), and exogenous insulin administration or oral meglitinide/sulfonylurea intake (they increase the risk for hypoglycaemia during and after exercise training). Clinicians using the EXPERT tool have the opportunity to select these medications so that exercise prescription can be further adapted according to medication intake.
Step 4: Adverse events during exercise testing
Adverse events during exercise testing that significantly affect exercise prescription, are also taken into account: myocardial ischaemia (in which the myocardial ischaemia threshold should be preferred as upper exercise intensity threshold), exercise-induced atrial fibrillation (altering exercise heart rate or the atrial fibrillation threshold should be preferred as upper exercise intensity marker), and presence of ICD (in which 10-20 beats below the ICD firing threshold should be preferred as the upper exercise intensity threshold). Clinicians have the opportunity to select these conditions and the exercise prescription will be further adapted according to these selections. Furthermore, cardiopulmonary exercise testing should preferentially be performed in patients with different CVD risk factors due to increased test-sensitivity for myocardial ischaemia and other co-morbidities.
Exercise training recommendations and exercise safety advices
After execution of these four steps, the EXPERT tool is ready to generate an exercise prescription aiming to optimise the clinical benefits and medical safety of exercise training (see Figure 1 and 2). In addition, contraindications for certain types of exercise, as well as which safety precautions should be taken into account, are clearly mentioned in the advice concerning medical safety. The safety advice includes which symptoms during exercise training may be anticipated and how to monitor these, and how to adapt training modalities to prevent eliciting/worsening in these symptoms. This exercise prescription can always be individually tailored by the clinician, stored and consulted during follow-up. In addition, web links to the most recent EAPC position statements on exercise training and rehabilitation are provided.
Definitions of different ranges of exercise intensity that were used in the EXPERT tool are mentioned in Table 3 . 37 The interactive EXPERT tool: capturing user requirements and prototyping
The EXPERT tool guides the user in bringing all contributing factors for the particular patient in perspective and proposes an adaptable exercise training recommendation. In this way, the EXPERT tool invites the user to explore possibilities and perform simulations, by showing the effect on the exercise training recommendation of changing the selections of contributing factors (CVDs, CVD risk factors, medication, etc.). In short, the envisioned EXPERT tool would function as a training and decision support system for the rehabilitation expert.
An interactive, semi-functional prototype of the EXPERT tool, focusing on the overall workflow supported by the tool and on the initial 'look and feel' and interactivity of the tool, was realised by the HumanComputer Interaction (HCI) group of Hasselt University. A preliminary version was demonstrated for the EXPERT group in May 2015 at EuroPrevent Lisbon and was welcomed by positive comments. Based on the experts' feedback, the prototype was further elaborated upon to be discussed again with the members of the EXPERT group in August 2015 at European Society of Cardiology (ESC) London. Following this second round of expert feedback in the EXPERT group meetings, a small-scale formative user test was organised with local rehabilitation experts of Jessa Hospital in Belgium and members of the EXPERT working group. In the local setting, HCI techniques such as observations and thinking aloud were used to optimally capture user requirements. Throughout the prototyping process, attention was given to functional features of the EXPERT tool, the recommendation algorithm and user experience. Besides assessing the overall concept of the EXPERT tool as a training and decision support system recommending exercise prescriptions for CV rehabilitation, this user testing stage has allowed us to define and test an initial validation protocol for the next stages of the project.
Results of comparison of exercise training advices by EXPERT tool vs cardiologists/ CV rehabilitation specialists
Eighteen cardiologists and physiotherapists involved in CV rehabilitation agreed to propose exercise training HR max : maximal heart rate; HRR: heart rate reserve; METs: metabolic equivalents; RPE: ratings of perceived exertion; VO 2peak : peak oxygen uptake. Source: Based on reference 37.
modalities for five imaginary patient cases (see Appendix 1, leading to 81 valid case comparisons). This exercise advice was then compared with the advice from the EXPERT tool. From this comparative study, it was generally noticed that:
The range in prescribed endurance exercise training intensity (based on percentage maximal heart rate (HR max )) by the clinicians was large, and in 60 patient cases (74% of all cases) the exercise intensity range did not correspond with the EXPERT tool. In all 81 cases the patient was required to do strength training exercises, and we observed that clinicians proposed this activity in 58 cases (72% of all cases). In all 81 cases the patient was required to execute additional types of exercises, and we observed that clinicians proposed these activities in 20 cases (25% of all cases). The recommended minimal programme duration by the clinicians showed a large range (from three up to 52 weeks) and was often shorter when compared to the EXPERT tool: in 37 patient cases (46% of all cases) this was <12 weeks. The proposed exercise frequency and exercise session duration corresponded well with the EXPERT tool prescriptions.
Discussion
In the present article, the concept, definitions and construction methodology of the EXPERT tool, a digital training and decision support system for optimised exercise prescription in CVD (risk), has been explained in detail. Such a description allows future users of the EXPERT tool to understand the fundamentals of its function. The EXPERT tool was developed over a three-year period. The development phase consisted of (a) the formation of a representative working group, (b) multiple meetings and discussions in the working group to reach consensus, (c) the construction of this tool, and (d) multiple validation phases with further optimisation of the tool. Eventually, a training and decision support system for exercise prescription in patients with CVD (risk) has been developed which automatically activates CVD risk factors (with accessory exercise prescription) during input of patient characteristics, and allows clinicians to select up to 10 primary indications for rehabilitation, five CVD risk factors and three chronic non-CV diseases. It also allows clinicians to select certain CV medications (with significant impact on exercise prescription) and adverse events during exercise testing. The tool then automatically calculates the most optimal exercise prescription (exercise training intensity, frequency, duration, type, session and programme duration, additional exercise training modalities) based on this input, and it generates exercise training safety advices to optimise medical safety of exercise training. This exercise prescription can be changed by the clinician anytime and it allows clinicians to collect patient data and to review exercise prescriptions during follow-up. It thus follows that the EXPERT tool is the first digital system that allows and generates such detailed and comprehensive exercise prescriptions for patients with CVD, taking so many clinical aspects into account, and combining this information within one patient. However, in this tool currently no difference in exercise prescription is being made between inpatient and outpatient settings, or between supervised and unsupervised programmes. It thus follows that clinicians who prescribe exercise should take these factors and circumstances into account to optimise medical safety and practical implementation. Despite the automatic calculation of exercise prescription by the EXPERT tool, it remains the full responsibility of the clinician to guarantee optimal medical safety and feasibility of exercise intervention.
The need for the standardisation of exercise prescription in CV rehabilitation throughout Europe was further confirmed by our own study in which exercise prescriptions by 18 CV rehabilitation experts for five imaginary patient cases were compared with exercise prescriptions generated by the EXPERT tool. The EXPERT tool interprets current European exercise recommendations and expert opinions. It was noticed that the prescribed exercise intensities by the clinicians were very often higher or lower, strength training exercises and additional exercise training strategies were prescribed less frequently, and the rehabilitation programme duration was often shorter, when compared to the EXPERT tool advice. It is thus felt that by the implementation and use of the EXPERT tool, many clinicians will be stimulated to reconsider their exercise prescriptions.
The next step in this project is the clinical implementation of the EXPERT tool in CV rehabilitation settings and hospitals throughout Europe. This will allow the EXPERT working group to collect a large amount of data on many CVD (risk) patients in rehabilitation programmes to contribute to further understanding of current exercise training prescription in Europe and the expected benefits of the selection of different exercise training modalities on short-and long-term clinical outcomes or exercise training adherence/drop-out. As such, these data may lead to refinements of current exercise training recommendations. Moreover, it is speculated that the use of the EXPERT tool in exercise prescription may lead to significantly greater clinical benefits, cost savings and innovative approaches to exercise prescription in clinical practice. Since the last decade, technological progress has led to a 'revolution' in rehabilitation medicine: tele-rehabilitation of heart disease patients is a good example of how the use and implementation of these new technologies in clinical medicine leads to better treatment and outcomes. 38, 39 Another potential opportunity is thus to implement the EXPERT tool in such tele-rehabilitation programmes.
Future activities within the EXPERT working group are anticipated to continue to adhere to the EXPERT working group goals, such as:
1. Further refinement of the EXPERT tool and implementation throughout the cardiology community.
To provide a state-of-the-art digital tool for exercise prescription, it is mandatory to regularly update exercise training recommendations, 2. Epidemiological European study on (a) current exercise prescription in clinical practice and its agreement with clinical guidelines (within different centres, regions and countries), and (b) the clinical impact of the EXPERT tool-based cardiac rehabilitation vs. usual cardiac rehabilitation.
Such studies are needed to further optimise the construct and design of the EXPERT tool, but also to be able to examine relations between exercise prescription and clinical benefits or therapy adherence in various CVD risk factors and diseases, and to examine whether a digitally supported exercise prescription eventually leads to significantly greater clinical benefits and cost savings, as opposed to current exercise prescription throughout Europe. Such data can also contribute to a further refinement of clinical exercise training recommendations.
One current limitation of the EXPERT tool may be that it has not yet been thoroughly validated in clinical practice, although we have compared exercise prescriptions as generated by 18 clinicians with exercise prescriptions as generated by the EXPERT tool. As a result, efforts should be made to continue executing such studies with this tool.
In conclusion, optimal exercise prescription remains a challenge due to the complexity of the combination of different CVDs or CVD risk factors, the influence of pharmacological treatment and the presence of chronic non-CV diseases or adverse events during exercise testing. In this project, an interactive training and decision support system (the EXPERT tool) was developed with the aim of assisting healthcare providers to better achieve this goal. The current article gives a detailed overview of the concept, definitions and construction methodology of this tool as well as the results of the testing in order to provide a clear understanding of its rationale and function. DH, PD, KC, LV, MFP, JN, VC, RP, EG, GRR, UC, JPS,  EG, CHD, FE, AA, BR, MA, SSB, OB, PB, MB, RF, PF,  EGP, EK, ML, DN, RR, MAS, CS, TT, Hansen D. The EAPC Exercise Prescription in Everyday Practice & Rehabilitation Training (EXPERT) tool -a digital decision support system for optimize exercise prescription in cardiovascular disease (risk). 13 Congress GICR-IACPR, Genova, October 2016.
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